Intuitive Surgical, Inc. $ISRG Stock Acquired by Seilern Investment Management Ltd

Seilern Investment Management Ltd grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 133,918 shares of the medical equipment provider’s stock after acquiring an additional 18,223 shares during the period. Intuitive Surgical accounts for approximately 6.8% of Seilern Investment Management Ltd’s portfolio, making the stock its 3rd largest holding. Seilern Investment Management Ltd’s holdings in Intuitive Surgical were worth $54,455,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Invesco Ltd. lifted its holdings in Intuitive Surgical by 17.4% during the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock worth $2,338,350,000 after purchasing an additional 611,268 shares in the last quarter. Bank of America Corp DE boosted its stake in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares during the period. Bank of New York Mellon Corp purchased a new position in Intuitive Surgical during the 2nd quarter valued at about $1,335,753,000. J. Stern & Co. LLP grew its holdings in Intuitive Surgical by 18,504.6% during the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after buying an additional 2,115,814 shares in the last quarter. Finally, Amundi grew its holdings in Intuitive Surgical by 8.6% during the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after buying an additional 193,096 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: UBS reiterated a Buy rating and maintained a $500 price target, citing Intuitive Surgical’s long-term growth runway for robotic-assisted surgery. Intuitive Surgical Buy Rating Reiterated on Long-Term Robotic Growth Runway
• Positive Sentiment: Erste Group Bank modestly raised its FY2027 earnings-per-share forecast to $10.09 from $10.06. The new estimate is also above the current consensus forecast of $8.87 for the current year, signaling improving expectations for future profitability.
• Positive Sentiment: Zacks identified ISRG as a sales-growth stock to consider as third-quarter earnings season begins, highlighting its strong revenue growth, cash generation and business momentum. 3 Sales Growth Stocks to Buy as Q3 Earnings Get Underway
• Neutral Sentiment: Investors have been searching heavily for Intuitive Surgical, increasing the stock’s visibility ahead of earnings but not necessarily indicating a change in fundamentals. Investors Heavily Search Intuitive Surgical
• Neutral Sentiment: Intuitive Surgical is expected to report quarterly earnings, making the upcoming results, procedure growth and management outlook important near-term catalysts. Intuitive Surgical Expected to Post Quarterly Earnings
• Negative Sentiment: BTIG lowered its price target to $454 from $469, although it retained a Buy rating. The cut suggests more limited near-term upside and may weigh on sentiment despite continued confidence in the company. Intuitive Surgical Stock Price Target Lowered at BTIG Research

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $6.43 during midday trading on Tuesday, hitting $421.21. 699,164 shares of the company’s stock were exchanged, compared to its average volume of 2,407,277. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock has a 50-day moving average price of $387.41 and a two-hundred day moving average price of $410.47. The company has a market cap of $148.80 billion, a P/E ratio of 48.24, a PEG ratio of 3.20 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the company earned $1.81 EPS. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on ISRG. Sanford C. Bernstein reissued an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Evercore set a $430.00 price objective on shares of Intuitive Surgical in a research note on Monday, July 6th. HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective for the company. in a research note on Thursday, July 30th. Royal Bank Of Canada decreased their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday, July 13th. Finally, Stifel Nicolaus lowered their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $498.83.

Insider Activity at Intuitive Surgical

In related news, Director Gary S. Guthart sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the sale, the director directly owned 1,245,679 shares of the company’s stock, valued at $498,271,600. This trade represents a 0.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the sale, the executive vice president directly owned 881 shares in the company, valued at $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock valued at $4,891,989 in the last ninety days. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.